To our knowledge, we demonstrate for the first time that CEH is a potentially effective MDR reversal agent for ESCC, based on downregulation of the mRNA expression of MDR1 and P-gp. This evidence concerns the gene ABCB1 and esophageal squamous cell carcinoma.